News
Diverse Drug-Resistant Cancer Cells Share a Hidden Weakness
UC San Francisco researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types. The findings, published in Nature on November 1, 2017, suggest a promising new approach to preventing cancer recurrence, if they can be
UCSF Launches Landmark $5B Fundraising Campaign to Solve the Most Complex Human Health Problems
UC San Francisco on Friday launched one of the largest fundraising efforts ever set by a U.S. university, a $5 billion campaign aimed at tackling the most complex biomedical questions of our day and working more broadly to improve the quality of people’s health over their lifetimes. Rising health
Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One
Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and University of California San Francisco will combine vast data stores, supercomputing, and scientific expertise to reinvent discovery process for cancer medicines SAN FRANCISCO, Oct 27, 2017 --
UCSF's Cryo-Electron Microscopy Advancements Bring Atomic-Level Life into Clearer View
UC San Francisco researchers recently captured exquisite images of a protein caught in the act of binding to a novel therapeutic drug with enough resolution to model how the individual atoms of the protein and drug lined up. Until recently, such a feat would have been considered impossible, but in
Big Data Shows How Cancer Interacts with Its Surroundings
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread. The new
Researchers to Combat Drug-Resistant Lung Cancer at New NCI-Funded Center at UCSF
The National Cancer Institute (NCI) has announced that UC San Francisco will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016. The center, a collaboration with researchers at Stanford University
Renowned Cancer Virologists to Deliver Annual Sokolow Lectureship
Two of the sharpest minds in the field of cancer virology are scheduled to present the Maurice, Ethel, and Jane Sokolow Memorial Cancer Endowment Lectureship at the HDFCCC on October 25th and 26th. Yuan Chang, MD, and Patrick S. Moore, MD, MPH, from the University of Pittsburgh Cancer Institute